Compare FRNM & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRNM | IMTX |
|---|---|---|
| Founded | 2014 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2024 | 2020 |
| Metric | FRNM | IMTX |
|---|---|---|
| Price | $17.01 | $7.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 8 |
| Target Price | ★ $18.00 | $17.63 |
| AVG Volume (30 Days) | 577.5K | ★ 651.0K |
| Earning Date | N/A | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $236.79 | N/A |
| Revenue Next Year | $11.16 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.97 | $7.47 |
| 52 Week High | $17.50 | $12.41 |
| Indicator | FRNM | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 63.50 | 32.64 |
| Support Level | $15.28 | N/A |
| Resistance Level | $17.34 | $10.74 |
| Average True Range (ATR) | 0.95 | 0.37 |
| MACD | -0.08 | -0.05 |
| Stochastic Oscillator | 83.85 | 17.75 |
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.